Trending...
- STS Capital Partners is pleased to announce the appointment of Barry Brown as Vice President, Business Development
- Regcrest LLC Publishes Free 50-State Tax Account Closure Checklist Tool
- Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
Product helps public and private entities
manage disease status enabling a safe return to work/school
manage disease status enabling a safe return to work/school
WEST CHESTER, Pa. - PennZone -- Faced with an evolving pandemic and continued vaccine hesitancy, workplaces, schools, and other organizations are searching for solutions to help them manage their risk and get back to normal. OnPacePlus, a leading provider of solutions for empowering patients and medical providers announces the availability of our CoviSecure risk management product. CoviSecure provides tracking of exposure, symptoms, vaccine status, contact tracing and quarantine status for any organization needing help managing risk for their workforce, students or other population. In partnership with Mathematica, CoviSecure leverages Mathematica's 19&Me algorithm providing an individual their personalized risk score for COVID-19. Using CoviSecure individuals and communities can assess their safety in their return to the workplace or school.
CoviSecure is delivered as a series of quick and easy interviews on a mobile phone, tablet, or computer browser. The interviews can be completed in less than a minute, providing real-time status information to individuals and the organization. The data can be leveraged to navigate a safe return or to manage overall risk factors requiring further action.
More on The PennZone
Dr. Christopher Williams, founder and CEO of OnPacePlus commented, "In developing CoviSecure, we sought input from a variety of doctors, corporate risk managers, and educational institutions to craft a product that would help mitigate the pandemic's effects on both public and private institutions. We developed product features to allow ease of use and the efficient capture of critical information empowering real-time decisions on workforce management. Using CoviSecure, organizations can manage risk efficiently and make informed decisions that help save time, precious resources, and ultimately lives."
CoviSecure provides an individual's personalized risk score following each interview, based on an advanced algorithm created by Mathematica, a premiere research and digital services organization with expertise at the intersection of data, methods, policy, and practice headquartered in Princeton, NJ and with offices throughout the U.S. and abroad.
The product is now widely available, affordably priced, and ready for implementation within your organization.
For more information, please contact OnPacePlus at (800) 428-4844 or by email at getcovisecure@onpaceplus.com.
CoviSecure is delivered as a series of quick and easy interviews on a mobile phone, tablet, or computer browser. The interviews can be completed in less than a minute, providing real-time status information to individuals and the organization. The data can be leveraged to navigate a safe return or to manage overall risk factors requiring further action.
More on The PennZone
- Notaron Expands Online Notarization Access Following Wisconsin Approval
- Wings Air Helicopters Selected to Support VIP Transportation for Resorts World in New York
- Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Houston This October
- The Social Capital Revolution Comes to Phoenix!
- Lawsuit Alleges American Deli Food Caused Severe Illness, Acute Kidney Failure, And Eight-day Hospitalization
Dr. Christopher Williams, founder and CEO of OnPacePlus commented, "In developing CoviSecure, we sought input from a variety of doctors, corporate risk managers, and educational institutions to craft a product that would help mitigate the pandemic's effects on both public and private institutions. We developed product features to allow ease of use and the efficient capture of critical information empowering real-time decisions on workforce management. Using CoviSecure, organizations can manage risk efficiently and make informed decisions that help save time, precious resources, and ultimately lives."
CoviSecure provides an individual's personalized risk score following each interview, based on an advanced algorithm created by Mathematica, a premiere research and digital services organization with expertise at the intersection of data, methods, policy, and practice headquartered in Princeton, NJ and with offices throughout the U.S. and abroad.
The product is now widely available, affordably priced, and ready for implementation within your organization.
For more information, please contact OnPacePlus at (800) 428-4844 or by email at getcovisecure@onpaceplus.com.
Source: OnPacePlus
0 Comments
Latest on The PennZone
- European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
- VICTURY Sports Announces Formation of Youth Sports League Built on the Official, Patented, and Award-Winning Keepy Uppy® Ball
- Spearmint Publishes Full Design of Its Mining Pool Before Building It, Including Legal Drafts
- Congressman Chuck Edwards (NC-11) Presents ReadyCommunities Partnership 2026 National Service Award to Local Businessman / US Air Force Veteran
- Cress Creeks Farm Opens Fall Corn Maze and Baby Lamb Hayride Experience in Ellijay, Georgia
- Brewtay Coffee Introduces Specialty Instant Line Designed for High-Velocity Commuters and Travelers
- Allstream Energy Partners Nominated in Multiple Categories for Fast Company's Best Workplaces for Innovators
- Ten Ten Ten Awards Provisional Certification to Cara AI for Home-Based Health Assessments
- IDI Consulting Partners with the American Heart Association to Advance Heart Health Awareness
- Kerri Lawless Introduces New Home-Selling Option for Local Homeowners
- Bethany Nikitenko Appointed to Philadelphia Trial Lawyers Association Diversity Committee
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
- Shelter Structures America makes European debut at TEMPOR EXPO 2026 in Fulda, Germany
- The Culture and Travel Report Enters a New Chapter as Travel and Hospitality Brands Take Notice
- Regcrest LLC Publishes Free 50-State Tax Account Closure Checklist Tool
- HydroExcavation.com Relaunches With Exclusive Local Service Areas and Dedicated Hydrovac Manufacturer Directory
- Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
- OneVizion Launches Vera AI, Bringing Connected Operational Context to Infrastructure Teams
- P-Wave Press Announces Pushing the Wave 2025 by L.A. Davenport